Background and Evolution Blackstone Life Sciences (BXLS) is the life-sciences investment arm of Blackstone, the world's largest alternative

A delicate French dessert must rise perfectly under precise conditions. In biotechnology, Soufflé Therapeutics — a newly unveiled venture named after

Introduction The Variable Capital Company (VCC) represents a transformative development in Singapore's fund management landscape, particularly for healthcare

Introduction Special Purpose Vehicles (SPVs) play a pivotal role in the pharmaceutical and biotechnology sectors, facilitating innovative financing and structuring

Bankruptcy remoteness is a crucial concept in structuring financial deals — especially royalty financing transactions in the biotechnology and pharmaceutical industry.

The week saw concentrated M&A activity focused on MASH and neurological assets totalling over $10 billion in deal

The Allure of the "Up To" Deal Every so often, a biotech startup announces a blockbuster partnership with

Executive Summary CureDuchenne Ventures does not operate as a traditional venture capital firm. Instead, it represents a venture philanthropy model

Introduction Rome Therapeutics is a Boston-based biotechnology company on a mission to drug the "dark genome" – the vast

Introduction In recent months, several major biopharma companies have dramatically scaled back or outright halted their gene and cell therapy